CAI NASDAQ
Caris Life Sciences, Inc.
1W: +8.2%
1M: +6.0%
3M: +116.0%
YTD: +24.8%
1Y: +8.4%
$33.67
+1.22 (+3.74%)
Weekly Expected Move ±9.6%
$26
$29
$32
$35
$38
Credit Risk of going bust: lower than 54% of companies Debt: 4.5% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.19 (down 99.4%), Caris Life Sciences, Inc. would be worth roughly what it owes.
Total debt $452.4M against a stock market value of $9.52B.
Distance to default 5.56 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $196.7M (short-term plus half of long-term), stock volatility 68.2%; Altman Z'' -0.33. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.19 (down 99.4%), Caris Life Sciences, Inc. would be worth roughly what it owes.
Total debt $452.4M against a stock market value of $9.52B.
Distance to default 5.56 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $196.7M (short-term plus half of long-term), stock volatility 68.2%; Altman Z'' -0.33. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (100)
Caris Life Sciences, Inc. (NASDAQ:CAI) Stock Has Average Price Target of $27.82 According to Analysts
Caris Life Sciences (NASDAQ:CAI) Shares Up 7.6% – What’s Next?
Caris Life Sciences, Inc. $CAI Shares Newly Bought by City Center Advisors LLC
$CAI stock is down 10% today. Here's what we see in our data. - Quiver Quantitative
CAI Dec 2027 35.000 call (CAI271217C00035000) interactive stock chart - Yahoo Finance Australia
CAI Mar 2027 12.500 put (CAI270319P00012500) Stock Historical Prices & Data - Yahoo! Finance Canada
CAI Oct 2026 20.000 put (CAI261016P00020000) interactive stock chart - Yahoo Finance Australia
CAI 261016 22.50C (CAI261016C22500) Stock Options Chain | Quotes & News - Moomoo
Caris Life Sciences, Inc. (CAI) stock price, news, quote and history - Yahoo Finance UK
IPO Stock Of The Week: Caris Pulls Back After More Than Doubling In Just Two Months
Caris Life Sciences (NASDAQ:CAI) Stock Price Down 6% - Here's What Happened - MarketBeat
Caris Life Sciences (NasdaqGS:CAI) Stock Forecast & Analyst Predictions - Simply Wall Street
Caris Life Sciences, Inc. (CAI) stock price, news, quote and history - Yahoo Finance Singapore
Caris Life Sciences Unveils the Next Evolution of Liquid Biopsy with Enhanced Caris Assure
GRAIL sets new 52-week high as FDA panel backs cancer test
Caris Life Sciences Coasts Past A Buy Point; Why This Texas Biotech Researcher Deserves A Look
Are Medical Stocks Lagging Bristol Myers Squibb (BMY) This Year?
Are Medical Stocks Lagging Bristol Myers Squibb (BMY) This Year?
Caris Life Sciences Stock Jumped 10% Yesterday. Here’s Where Shares Could Go Further in 2026.
Caris Life Sciences Stock Jumped 10% Yesterday. Here’s Where Shares Could Go Further in 2026. - TIKR.com
Caris Life Sciences: Diagnostics Growth With Room To Run (NASDAQ:CAI) - Seeking Alpha
Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division
Strength Seen in Revvity (RVTY): Can Its 9.1% Jump Turn into More Strength?
Strength Seen in Revvity (RVTY): Can Its 9.1% Jump Turn into More Strength?
Caris Life Sciences, Inc. (CAI) Soars 9.4%: Is Further Upside Left in the Stock?
Caris Life Sciences, Inc. (CAI) Soars 9.4%: Is Further Upside Left in the Stock? - Yahoo Finance
Caris Life Sciences, Inc. (CAI) Soars 9.4%: Is Further Upside Left in the Stock?
Caris Life Sciences (NASDAQ:CAI) Trading 3.9% Higher - What's Next? - MarketBeat
New investor pitch from Caris Life Sciences (CAI) set for Morgan Stanley healthcare event - Stock Titan
Amundi Buys 1,197,392 Shares of Caris Life Sciences, Inc. $CAI - MarketBeat
Squarepoint Ops LLC Acquires Shares of 380,927 Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences Launches New National Commercial Featuring Kevin Costner to Raise Awareness of Early Cancer Detection and Caris Detect
Could Caris Life Sciences (CAI) Be 7% Undervalued After Its Lung Cancer Research Update?
David Baxley Spetzler Sells 478,000 Shares of Caris Life Sciences (NASDAQ:CAI) Stock
Could Caris Life Sciences (CAI) Be 7% Undervalued After Its Lung Cancer Research Update? - Yahoo Finance
Caris Life Sciences (CAI) Will Present Seven Studies At A Global Lung Conference
Bank of New York Mellon Corp Takes Position in Caris Life Sciences, Inc. $CAI
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer
One lung tumor pattern was linked to shorter survival and fewer immune cells. Caris studied 39,124 samples. - Stock Titan
Caris Life Sciences, Inc. (NASDAQ:CAI) Receives $26.33 Average Price Target from Brokerages
Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer
Caris Life Sciences Stock Is Up 65% in Three Months, But Its Valuation Multiple Just Got Cheaper. - tikr.com
What’s Next For Caris Life Sciences (CAI) After 21% Jump?
Bank of New York Mellon Corp Purchases 181,258 Shares of Caris Life Sciences, Inc. $CAI
Caris Life Sciences: Guidance Raised, Valuation Still Attractive - Seeking Alpha
Caris Life Sciences Inc. (CAI) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Why Caris Life Sciences (CAI) Stock Is Up Today - Quiver Quantitative
Caris Life Sciences (NASDAQ:CAI) Shares Gap Up - Here's Why - MarketBeat
Caris Life Sciences, ECOG-ACRIN and NRG Oncology Study Demonstrates Multimodal AI Approach to Predict Late Distant Recurrence Risk in HR+ Early Breast Cancer
Caris Life Sciences, Inc. Q2 2026 Earnings Call Summary
Caris Life Sciences Inc (CAI) (Q2 2026) Earnings Call Highlights: Record Revenue and Volume ...
Caris forecasts $1.03B-$1.04B 2026 revenue as it scales Detect capacity toward $3B run rate
Caris Life Sciences, Inc. - Common Stock (CAI) Stock Price, News, Quote & History - FinancialContent
Caris Life Sciences Q2 Earnings Call Highlights
Caris Life Sciences,?Inc. (CAI) Reports Break-Even Earnings for Q2
Caris Life Sciences,?Inc. (CAI) Reports Break-Even Earnings for Q2 - Yahoo Finance
Caris Life Sciences,?Inc. (CAI) Reports Break-Even Earnings for Q2
Caris Life Sciences, Inc. GAAP EPS of $0.00 misses by $0.01, revenue of $263.7M beats by $25.62M
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Caris Life Sciences (NYSE: CAI) lifts Q2 revenue and nears breakeven - stocktitan.net
Caris Launches Multi-Cancer Blood Test; Q2 Cases Total About 59,200 - stocktitan.net
Caris Life Sciences Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
symbol__ Stock Quote Price and Forecast - CNN
Renaissance Technologies LLC Acquires 120,000 Shares of Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences, Inc. (NASDAQ:CAI) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Arrowstreet Capital Limited Partnership Acquires New Holdings in Caris Life Sciences, Inc. $CAI - MarketBeat
Caris Life Sciences, Inc. SEC Filing (Aug 3, 2026) - stocktitan.net
Cairo Communication (BIT:CAI) Stock Faces Margin Squeeze After Wider Quarterly Loss - webull.com
Caris Life Sciences, Inc. $CAI Shares Acquired by Sei Investments Co. - MarketBeat
CareDx (CDNA) Beats Q2 Earnings and Revenue Estimates
Caris Life Sciences (CAI) Stock Looks Undervalued On A 47% Slump
Caris Life Sciences (CAI) Sets August Results Date, Is The Stock Undervalued?
Caris Life Sciences (CAI) Launches In House PTEN Test After FDA Prostate Cancer Approval
Caris Life Sciences (CAI) Stock Looks Undervalued On A 47% Slump - Yahoo Finance
Caris Life Sciences (CAI) Stock Looks Undervalued Even As Caution Persists - simplywall.st
Caris Life Sciences (CAI) Sets August Results Date, Is The Stock Undervalued? - Yahoo Finance
Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing
Caris Life Sciences (CAI) Launches Caris Detect Multi-Cancer Screening Test
Tesla, AMD, and SpaceX headline Cathie Wood's biggest H1 portfolio bets
Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test
Is Caris Life Sciences, Inc. (CAI) Stock Positioned for Growth With AI-Driven Precision Medicine Expansion?
Is Caris Life Sciences, Inc. (CAI) Stock Positioned for Growth With AI-Driven Precision Medicine Expansion?
Is Caris Life Sciences, Inc. (CAI) Stock Positioned for Growth With AI-Driven Precision Medicine Expansion? - Yahoo Finance
Is Caris Life Sciences, Inc. (CAI) A Good Stock To Buy Now?
Is Caris Life Sciences, Inc. (CAI) A Good Stock To Buy Now?
Is Caris Life Sciences, Inc. (CAI) A Good Stock To Buy Now? - Yahoo Finance
Caris Life Sciences (CAI) Announces $100M Share Repurchase Program
Caris Life Sciences Announces That It’s Dual Listing on NYSE Texas
Caris Life Sciences Announces Dual Listing on NYSE Texas
As the GLP-1 race heats up, how can investors position themselves for the next wave of innovation?
Stock Market Today: Nasdaq 100 Slips As Broadcom Plunges, Bitcoin Hits 4-Month Lows
$CAI stock is down 15% today. Here's what we see in our data. - Quiver Quantitative
Caris Life Sciences Eyes Bigger Oncology Market After IPO as Revenue Jumps 79%
Caris Life Sciences Director Makes Bold Insider Move With Major Stock Purchase - TipRanks
[SCHEDULE 13G/A] Caris Life Sciences, Inc. Amended Passive Investment Disclosure - Stock Titan
Caris Life Sciences Inc (CAI) Stock Price Quote Today & Current Price Chart - Capital.com
J.H. Whitney reports 18.26M shares of Caris Life Sciences (CAI) - Stock Titan
Director buys 31K Caris Life Sciences (CAI) shares around $16.15 - Stock Titan
Caris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene Panels